ERBB2 and renal pelvis/ureter urothelial carcinoma: ERBB2 alterations were more common in tumors with a bladder primary site versus tumors arising in the ureter or renal pelvis (22.0% for bladder vs 16.5% for upper tract urothelial cancers (UTUC), p = 0.042, Supplementary Fig. 1B).